Key Points
- Genus insider sale: Insider Jorgen Kokke sold 3,450 shares on May 13 at an average price of GBX 2,267, for a total of £78,211.50.
- Share performance: Genus stock was down 0.2% and opened at GBX 2,267.94, near the insider sale price.
- Analyst outlook remains positive: Despite the sale, analysts still rate Genus a Buy overall, with an average target price of GBX 3,216.67.
Genus plc (LON:GNS - Get Free Report) insider Jorgen Kokke sold 3,450 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of GBX 2,267, for a total transaction of £78,211.50.
Genus Stock Down 0.2%
GNS opened at GBX 2,267.94 on Thursday. The company has a current ratio of 2.25, a quick ratio of 1.08 and a debt-to-equity ratio of 55.10. Genus plc has a 1-year low of GBX 1,890 and a 1-year high of GBX 3,220. The company has a market capitalization of £1.51 billion, a PE ratio of 31.94, a PEG ratio of 2.87 and a beta of 0.90. The firm's 50 day simple moving average is GBX 2,530.56 and its two-hundred day simple moving average is GBX 2,638.36.
Genus (LON:GNS - Get Free Report) last announced its quarterly earnings data on Thursday, February 26th. The company reported GBX 60.80 earnings per share (EPS) for the quarter. Genus had a net margin of 7.07% and a return on equity of 9.70%. As a group, equities analysts forecast that Genus plc will post 70.9644323 EPS for the current year.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. Berenberg Bank reissued a "buy" rating and issued a GBX 3,350 price objective on shares of Genus in a research note on Monday. Deutsche Bank Aktiengesellschaft increased their price objective on shares of Genus from GBX 3,100 to GBX 3,300 and gave the stock a "buy" rating in a research note on Friday, January 16th. Finally, Shore Capital Group reissued a "buy" rating and issued a GBX 3,000 price objective on shares of Genus in a research note on Friday, January 16th. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of GBX 3,216.67.
Get Our Latest Research Report on GNS
About Genus
(
Get Free Report)
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
